Diploma (LON:DPLM – Get Free Report) released its quarterly earnings results on Tuesday. The company reported GBX 255.60 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Diploma had a return on equity of 18.55% and a net margin of 9.42%. The business had revenue of GBX 184.03 billion during the quarter.
Here are the key takeaways from Diploma’s conference call:
- Diploma reported a strong FY2026: organic revenue grew 15%, operating profit rose 42% to £487 million, and EPS increased 45%. Operating margin expanded 400 basis points to 26.5%, with return on capital at 25.3%.
- Management expects another strong year in FY2027, guiding to 6% organic growth and 12% total revenue growth, with further EPS growth. It expects double-digit organic growth in Q1, followed by slower growth in Q2 and Q3 against tougher comparisons.
- The company completed 16 acquisitions since the start of FY2026, investing £368 million and adding about £50 million of annualized operating profit; further deals completed after year-end are expected to contribute to FY2027. Management said its pipeline remains strong, while emphasizing returns discipline and available balance-sheet capacity.
- FY2027 operating margin is forecast at 25.5%, down from 26.5%, reflecting planned investment, lower margins at Peerless and dilution from acquisitions. Management also expects cash conversion to settle around 90% as it invests in inventory to support growth.
- Life Sciences had just 1% organic growth as healthcare markets remained challenging and more products than usual reached the end of their life cycles. Management expects near-term growth to remain modest, while pointing to a healthy longer-term product pipeline.
Diploma Price Performance
Shares of DPLM stock traded down GBX 130 on Wednesday, hitting GBX 6,855. 815,122 shares of the stock traded hands, compared to its average volume of 2,510,888. The firm has a market cap of £9.19 billion, a price-to-earnings ratio of 48.69, a PEG ratio of 2.82 and a beta of 0.92. Diploma has a 52 week low of GBX 4,970 and a 52 week high of GBX 7,980. The firm has a 50 day simple moving average of GBX 7,427.48 and a two-hundred day simple moving average of GBX 6,819.16. The company has a debt-to-equity ratio of 47.65, a current ratio of 2.06 and a quick ratio of 0.80.
Insider Buying and Selling at Diploma
In other news, insider Katie Bickerstaffe bought 246 shares of the company’s stock in a transaction that occurred on Wednesday, September 23rd. The stock was bought at an average price of GBX 7,696 per share, with a total value of £18,932.16. Company insiders own 1.14% of the company’s stock.
Top Diploma Stories
Here are a few of the latest stories about DPLM:
- Positive Sentiment: FY26 performance was strong: revenue reached £1.84 billion and adjusted operating profit rose 42% to £487.1 million, supported by organic growth and improved margins. The company also increased its dividend, adding to the positive shareholder-return picture. Diploma Reports 42% Rise in Adjusted Operating Profit
- Neutral Sentiment: Analysts’ views on Diploma’s FY27 outlook are divided, leaving uncertainty about the company’s near-term growth prospects after its strong annual results. Diploma’s FY27 outlook divides brokers despite strong annual results
- Negative Sentiment: Coverage described the shares as pausing after a breakneck 2026 run. That sharp prior advance, alongside uncertainty about FY27, may be prompting investors to reassess expectations and take profits. Diploma pauses for breath following breakneck 2026
Analyst Ratings Changes
A number of analysts have commented on DPLM shares. Royal Bank Of Canada restated an “outperform” rating and issued a GBX 7,400 price target on shares of Diploma in a research report on Tuesday, September 8th. JPMorgan Chase & Co. lifted their price objective on Diploma from GBX 5,760 to GBX 8,250 and gave the company an “overweight” rating in a research report on Monday, August 24th. Finally, Berenberg Bank reiterated a “buy” rating and set a GBX 9,000 price objective on shares of Diploma in a research note on Wednesday. Six research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 7,400.
Read Our Latest Research Report on DPLM
About Diploma
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Read More
- Five stocks we like better than Diploma
- 5 Consumer Discretionary Plays Showing Strength During the Tech Sell-Off
- NVIDIA’s Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?
- SpaceX’s Historic Starship Catch Raises a Bigger Question About Its AI Spending
- AMD Bets $8.2B on Physical AI: Could Robotics Be Its Next Growth Frontier?
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
